Pro Medicus (OTCMKTS:PMCUF) Shares Gap Up – Should You Buy?

Pro Medicus Limited (OTCMKTS:PMCUF)’s share price gapped up before the market opened on Monday. The stock had previously closed at $105.09, but opened at $116.33. Pro Medicus shares last traded at $116.33, with a volume of 1 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group cut shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One analyst has rated the stock with a Hold rating. According to data from MarketBeat, Pro Medicus currently has a consensus rating of “Hold” and a consensus price target of $155.00.

Pro Medicus Stock Performance

The stock has a 50-day simple moving average of $120.59 and a 200 day simple moving average of $113.34.

About Pro Medicus

Pro Medicus Limited is an Australian medical technology company that develops software for medical imaging and healthcare organizations. Its solutions are designed to help hospitals, radiology practices and other providers store, manage, view and distribute medical images and related clinical information.

The company’s principal platform is Visage 7, an enterprise imaging system developed and commercialized through its wholly owned subsidiary, Visage Imaging. The platform supports the review of diagnostic studies such as computed tomography, magnetic resonance imaging and other medical images, with an emphasis on enterprise-wide access, workflow efficiency and advanced visualization.

Founded in 1983 and headquartered in Melbourne, Australia, Pro Medicus serves healthcare customers in Australia, North America and Europe.